Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Remo H.M. Furtado, Otávio Berwanger, Henrique Fonseca, Thiago Domingos Corrêa, Leonardo José Rolim Ferraz, Maura G Lapa, Fernando G Zampieri, Viviane Cordeiro Veiga, Luciano César Pontes Azevedo, Régis Goulart Rosa, Renato D. Lópes, Álvaro Avezum, Airton L. O. Manoel, Felipe M T Piza, Priscilla A. de Martins, Thiago Lisboa, Adriano José Pereira, Guilherme Benfatti Olivato, Vicente C S Dantas, Eveline Pı́polo Milan, Otávio Gebara, Roberto Bleuel Amazonas, Monalisa B Oliveira, Ronaldo V P Soares, Diogo D F Moia, Luciana Pereira Almeida de Piano, Kleber Castilho, Roberta G.R.A.P. Momesso, Guilherme P P Schettino, Luiz Vicente Rizzo, Ary Serpa Neto, Flávia Ribeiro Machado, Alexandre Biasi Cavalcanti
Topics & Concepts
MedicineAzithromycinHydroxychloroquinePopulationClinical trialRandomized controlled trialInternal medicineMechanical ventilationOdds ratioClinical endpointNasal cannulaSurgeryCoronavirus disease 2019 (COVID-19)CannulaAntibioticsEnvironmental healthDiseaseBiologyInfectious disease (medical specialty)MicrobiologyCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research